Target Site Blocker (TSB) of the IL-17A-miR466I-3p iInteraction Prevents Progressive and Relapsing Remitting EAE
NCS1 - A New Target for Mood Disorders and Wolfram Syndrome
Cell Permeable Miniature Proteins
Paci-PHI: Evolution-Proof Therapy Against MDR Bacterial Pathogens
Lkit Therapeutics: Exploiting Synethtic Lethality to Target p53 Mutant Cancers Using First-In-Class Potent and Selective Small Molecule Inhibitors of Lipid Kinases PI5P4Kα/β.
